3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Stomach Neoplasms
13
Lung Neoplasms
9
Adenocarcinoma
5
Neoplasms
4
Neoplasm Metastasis
4
Esophageal Neoplasms
4
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Thymoma
1
Solid Tumors
1
Solid Cancer
1
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Metastatic Small Intestinal Adenocarcinoma
1
Metastatic Gastric Adenocarcinoma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Digestive System Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Clinical Stage IVB Gastric Cancer AJCC v8
1
Interventions
tusamitamab ravtansine
1
Ramucirumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Gastric
×
Ramucirumab
×
1 year
×
Clear all
NCT05071053
2025-08-22
CARMEN-GC01
Sanofi
Phase 2
Terminated
35 enrolled
14 charts